HUP9900511A2 - Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás - Google Patents
Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárásInfo
- Publication number
- HUP9900511A2 HUP9900511A2 HU9900511A HUP9900511A HUP9900511A2 HU P9900511 A2 HUP9900511 A2 HU P9900511A2 HU 9900511 A HU9900511 A HU 9900511A HU P9900511 A HUP9900511 A HU P9900511A HU P9900511 A2 HUP9900511 A2 HU P9900511A2
- Authority
- HU
- Hungary
- Prior art keywords
- adrenergic agonist
- cosmetical
- beta
- treating
- substance
- Prior art date
Links
- 239000000808 adrenergic beta-agonist Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 3
- 239000002537 cosmetic Substances 0.000 abstract 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 abstract 1
- 102100024304 Protachykinin-1 Human genes 0.000 abstract 1
- 101800003906 Substance P Proteins 0.000 abstract 1
- 239000000048 adrenergic agonist Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000003890 substance P antagonist Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Abstract
A találmány legalább egy -adrenergiás agőnista mint P anyagantagőnista alkalmazására vőnatkőzik kőzmetikai készítményekben vagygyógyszerkészítmény előállításánál, amely készítmények alkalmasakkülönböző, a P anyag főkőzőtt szintézisével és/vagy felszabadűlásávalkapcsőlatős elváltőzásők kezelésére. A találmány vőnatkőzik tővábbákőzmetikai kezelési eljárásra is, amelynél legalább egy -adrenergiásagőnistát tartalmazó készítményt visznek fel a bőrre, hajra és/vagy anyálkamembránőkra. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9512447A FR2740040B1 (fr) | 1995-10-23 | 1995-10-23 | Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9900511A2 true HUP9900511A2 (hu) | 1999-07-28 |
HUP9900511A3 HUP9900511A3 (en) | 2000-09-28 |
Family
ID=9483809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9900511A HUP9900511A3 (en) | 1995-10-23 | 1996-10-01 | Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating |
Country Status (14)
Country | Link |
---|---|
US (2) | US5958432A (hu) |
EP (1) | EP0769293B1 (hu) |
JP (1) | JP3636473B2 (hu) |
AR (1) | AR004052A1 (hu) |
BR (1) | BR9611302A (hu) |
CA (1) | CA2222311C (hu) |
DE (1) | DE69603681T2 (hu) |
DK (1) | DK0769293T3 (hu) |
FR (1) | FR2740040B1 (hu) |
HU (1) | HUP9900511A3 (hu) |
NO (1) | NO312273B1 (hu) |
PL (1) | PL186366B1 (hu) |
RU (1) | RU2169552C2 (hu) |
WO (1) | WO1997015281A1 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948972A (en) * | 1994-12-22 | 1999-09-07 | Kla-Tencor Corporation | Dual stage instrument for scanning a specimen |
WO2002007682A1 (en) * | 2000-07-26 | 2002-01-31 | Vyden John K | Methods for treating atopic disorders |
ITPD20010187A1 (it) * | 2001-07-23 | 2003-01-23 | Cutech Srl | Trattamento del follicolo polifero, in particolare contro la caduta dei capelli |
EP1295599A1 (en) * | 2001-09-21 | 2003-03-26 | Boehringer Ingelheim International GmbH | Method for the treatment of prevention of atopic dermatitis |
US20030219573A1 (en) * | 2002-03-27 | 2003-11-27 | Torgny Falk | Absorbent product |
US8343519B2 (en) * | 2003-02-19 | 2013-01-01 | L'oreal S.A. | Chemical enhancer and method |
EP1613266A4 (en) * | 2003-04-15 | 2009-05-06 | Theraquest Biosciences Llc | METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF |
JPWO2006054513A1 (ja) * | 2004-11-19 | 2008-05-29 | キッセイ薬品工業株式会社 | 神経因性疼痛の予防又は治療剤 |
AR054249A1 (es) | 2005-04-13 | 2007-06-13 | Astion Dev As | Tratamiento de enfermedades del tejido conectivo de la piel |
CA2715110A1 (fr) * | 2008-01-18 | 2009-09-17 | Centre National De La Recherche Scientifique (Cnrs) | Composes utilisables pour le traitement de douleurs neuropathiques |
GB0805535D0 (en) | 2008-03-27 | 2008-04-30 | Univ Leicester | Scar prevention |
US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
MX2011008878A (es) * | 2009-02-24 | 2011-09-21 | Novartis Ag | Usos de antagonistas de los receptores de nk. |
GB2513297A (en) | 2013-03-08 | 2014-10-29 | Univ Leicester | Methods |
WO2017007910A1 (en) | 2015-07-09 | 2017-01-12 | Galderma S.A. | Method of reducing hair loss associated with chemotherapy |
WO2019230230A1 (ja) * | 2018-05-29 | 2019-12-05 | 株式会社ナノエッグ | アトピー性皮膚炎を治療または予防するための組成物 |
WO2020051568A1 (en) * | 2018-09-08 | 2020-03-12 | Wen Tan | NEW USE OF R-ENANTIOMER OF ADRENERGIC β2 RECEPTOR AGONISTS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ITS EXTRA INTESTINAL MANIFESTATIONS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1474316A (en) * | 1975-02-12 | 1977-05-25 | Seperic | O-aminoalkyl oximes |
US4038417A (en) * | 1975-06-19 | 1977-07-26 | Nelson Research & Development Company | Method for treatment of psoriasis |
US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
US5366731A (en) * | 1990-08-24 | 1994-11-22 | Wisconsin Alumni Research Foundation | Cosmetic compositions containing secosterol compounds |
IL99368A (en) * | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
CA2114968A1 (en) * | 1993-02-25 | 1994-08-26 | John Wille | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
JPH07258067A (ja) * | 1994-03-18 | 1995-10-09 | Kao Corp | 浴用剤組成物 |
FR2719474B1 (fr) * | 1994-05-05 | 1996-05-31 | Oreal | Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue. |
-
1995
- 1995-10-23 FR FR9512447A patent/FR2740040B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-01 DE DE69603681T patent/DE69603681T2/de not_active Expired - Fee Related
- 1996-10-01 JP JP51633197A patent/JP3636473B2/ja not_active Expired - Fee Related
- 1996-10-01 RU RU97121883/14A patent/RU2169552C2/ru not_active IP Right Cessation
- 1996-10-01 HU HU9900511A patent/HUP9900511A3/hu unknown
- 1996-10-01 PL PL96324924A patent/PL186366B1/pl not_active IP Right Cessation
- 1996-10-01 WO PCT/FR1996/001530 patent/WO1997015281A1/fr active Application Filing
- 1996-10-01 DK DK96402098T patent/DK0769293T3/da active
- 1996-10-01 BR BR9611302A patent/BR9611302A/pt not_active IP Right Cessation
- 1996-10-01 EP EP96402098A patent/EP0769293B1/fr not_active Expired - Lifetime
- 1996-10-01 CA CA002222311A patent/CA2222311C/fr not_active Expired - Fee Related
- 1996-10-21 AR ARP960104829A patent/AR004052A1/es not_active Application Discontinuation
- 1996-10-23 US US08/731,967 patent/US5958432A/en not_active Expired - Fee Related
-
1997
- 1997-12-30 NO NO19976143A patent/NO312273B1/no unknown
-
1999
- 1999-05-12 US US09/310,099 patent/US6267972B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUP9900511A3 (en) | 2000-09-28 |
JP3636473B2 (ja) | 2005-04-06 |
FR2740040A1 (fr) | 1997-04-25 |
WO1997015281A1 (fr) | 1997-05-01 |
PL186366B1 (pl) | 2003-12-31 |
RU2169552C2 (ru) | 2001-06-27 |
DE69603681D1 (de) | 1999-09-16 |
US6267972B1 (en) | 2001-07-31 |
NO312273B1 (no) | 2002-04-22 |
EP0769293A3 (fr) | 1997-05-02 |
DK0769293T3 (da) | 1999-12-06 |
JP2000503628A (ja) | 2000-03-28 |
MX9710475A (es) | 1998-08-30 |
AR004052A1 (es) | 1998-09-30 |
US5958432A (en) | 1999-09-28 |
PL324924A1 (en) | 1998-06-22 |
BR9611302A (pt) | 1999-03-30 |
DE69603681T2 (de) | 1999-11-25 |
EP0769293B1 (fr) | 1999-08-11 |
FR2740040B1 (fr) | 1997-12-05 |
CA2222311A1 (fr) | 1997-05-01 |
NO976143L (no) | 1998-06-03 |
EP0769293A2 (fr) | 1997-04-23 |
NO976143D0 (no) | 1997-12-30 |
CA2222311C (fr) | 2006-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900511A2 (hu) | Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás | |
BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
BR9609532A (pt) | Composição antimicrobiana para o tratamento de cabelo processo para o tratamento de caspa e uso da composição | |
BR9704843B1 (pt) | hidroxifeniltriazinas, composiÇço, processo de estabilizaÇço de material orgÂnico, uso, preparaÇço cosmÉtica e processo de tratamento de cabelo humano. | |
DE69533581D1 (de) | Sprühbare zubereitungen enthaltend dispernierten pulvers sowie dessen anwendungsverfahren | |
ATE311849T1 (de) | Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate | |
BR9303433A (pt) | Composicao viscoelastica linear para a higiene ou cuidados pessoais,processo para a promocao da higiene e cuidados pessoais,processo para a fixacao dos cabelos,processo para a promocao da higiene e cuidados da pele,e,uso de um agente espessante polimerico | |
BR9503559A (pt) | Composição cosmeticamente aceitável processo para o tratamento de acne vulgaris composição para maquiagem facial | |
BR0204979A (pt) | Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de tintura de oxidação, de tratamento e descoloração das fibras queratìnicas humanas, e uso de pelo menos um silicone aminado | |
DE69718053D1 (de) | in vitro methoden und verwendung von pharmazeutische zusammensetzungen für die BEHANDLUNG VON INNENOHRHAARZELLEN | |
DK241588A (da) | Topisk haarvaekstmiddel | |
MX9801596A (es) | Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas. | |
MY107088A (en) | Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof | |
DE69628296D1 (de) | Verwendung von sophorolipiden zur herstellung kosmetischer produkte, insbesondere zur behandlung der haut | |
BR9903336B1 (pt) | composição cosmética, usos da composição e processo para o tratamento cosmético de substáncias queratìnicas. | |
AU1958195A (en) | Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same | |
ES2144239T3 (es) | Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. | |
BR9916440B1 (pt) | composiÇço tàpica, processo cosmÉtico para clareamento de pele humana e uso do Ácido linoleico conjugado e/ou derivados do mesmo. | |
UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
HUP9700153A2 (hu) | Glicerin-triacetát alkalmazása gombás körömmegbetegedés kezelésére alkalmazható gyógyászati készítmények előállítására | |
HUP9700806A2 (hu) | Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására | |
HUP0000642A2 (hu) | Izzadásgátló vagy dezodoráló készítmény, valamint eljárás előállítására | |
CA2232433A1 (fr) | Nouvelle composition reductrice et nouveau procede pour la deformation permanente des cheveux | |
FR2653015B1 (fr) | Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant. | |
BR9302646A (pt) | Composicao cosmeticamente aceitavel,adequada para aplicacao topica a pele,cabelos ou unhas,e,processo para tal tratamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |